0 TrioxBio is an innovative biotech company, developing novel drugs based on inhibition Nitric Oxide. The company focuses on orphan indications for Migraine, Cardio vascular and Dialysis treatment.

Our company believes it is developing promising new NOS inhibitors, to date having 2 ongoing clinical FDA trials in phase II . The company holds a substantial clinical database , collected from 420 patients. The leading candidate is a migraine small molecule tablet for the treatment of acute migraine showing superior safety and efficacy results in clinical trials compare to the current standard of care. Triox Bio is a development stage biotechnology company focused on bringing to market new products and new delivery systems to existing products.

While Triox Bio and GF Bio are the companies part of SK Pharma Group, involved in the R&D of innovative treatments for Oncology and Antiviral diseases and of new drug delivery systems. Learn More